767 related articles for article (PubMed ID: 20388854)
21. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast.
Cornblatt BS; Ye L; Dinkova-Kostova AT; Erb M; Fahey JW; Singh NK; Chen MS; Stierer T; Garrett-Mayer E; Argani P; Davidson NE; Talalay P; Kensler TW; Visvanathan K
Carcinogenesis; 2007 Jul; 28(7):1485-90. PubMed ID: 17347138
[TBL] [Abstract][Full Text] [Related]
22. Phytochemicals as Innovative Therapeutic Tools against Cancer Stem Cells.
Scarpa ES; Ninfali P
Int J Mol Sci; 2015 Jul; 16(7):15727-42. PubMed ID: 26184171
[TBL] [Abstract][Full Text] [Related]
23. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas.
Huang WC; Kuo KT; Adebayo BO; Wang CH; Chen YJ; Jin K; Tsai TH; Yeh CT
J Nutr Biochem; 2018 Apr; 54():140-150. PubMed ID: 29414668
[TBL] [Abstract][Full Text] [Related]
24. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling.
Chang CJ; Yang JY; Xia W; Chen CT; Xie X; Chao CH; Woodward WA; Hsu JM; Hortobagyi GN; Hung MC
Cancer Cell; 2011 Jan; 19(1):86-100. PubMed ID: 21215703
[TBL] [Abstract][Full Text] [Related]
25. Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer.
Simões BM; Santiago-Gómez A; Chiodo C; Moreira T; Conole D; Lovell S; Alferez D; Eyre R; Spence K; Sarmiento-Castro A; Kohler B; Morisset L; Lanzino M; Andò S; Marangoni E; Sims AH; Tate EW; Howell SJ; Clarke RB
Oncogene; 2020 Jun; 39(25):4896-4908. PubMed ID: 32472077
[TBL] [Abstract][Full Text] [Related]
26. Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway.
Xu W; Lin H; Zhang Y; Chen X; Hua B; Hou W; Qi X; Pei Y; Zhu X; Zhao Z; Yang L
J Exp Clin Cancer Res; 2011 Oct; 30(1):103. PubMed ID: 22032476
[TBL] [Abstract][Full Text] [Related]
27. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway.
An H; Kim JY; Lee N; Cho Y; Oh E; Seo JH
Biochem Biophys Res Commun; 2015 Oct; 466(4):696-703. PubMed ID: 26407842
[TBL] [Abstract][Full Text] [Related]
28. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
[TBL] [Abstract][Full Text] [Related]
29. Sulforaphane regulates the proliferation of leukemia stem-like cells via Sonic Hedgehog signaling pathway.
Wang F; Huang X; Sun Y; Li Z; Sun R; Zhao T; Wang M; Yan C; Liu P
Eur J Pharmacol; 2022 Mar; 919():174824. PubMed ID: 35157913
[TBL] [Abstract][Full Text] [Related]
30. Targeting Colorectal Cancer Proliferation, Stemness and Metastatic Potential Using Brassicaceae Extracts Enriched in Isothiocyanates: A 3D Cell Model-Based Study.
Pereira LP; Silva P; Duarte M; Rodrigues L; Duarte CM; Albuquerque C; Serra AT
Nutrients; 2017 Apr; 9(4):. PubMed ID: 28394276
[TBL] [Abstract][Full Text] [Related]
31. Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines.
Pledgie-Tracy A; Sobolewski MD; Davidson NE
Mol Cancer Ther; 2007 Mar; 6(3):1013-21. PubMed ID: 17339367
[TBL] [Abstract][Full Text] [Related]
32. Transition from colitis to cancer: high Wnt activity sustains the tumor-initiating potential of colon cancer stem cell precursors.
Shenoy AK; Fisher RC; Butterworth EA; Pi L; Chang LJ; Appelman HD; Chang M; Scott EW; Huang EH
Cancer Res; 2012 Oct; 72(19):5091-100. PubMed ID: 22902411
[TBL] [Abstract][Full Text] [Related]
33. The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice.
Pham NA; Jacobberger JW; Schimmer AD; Cao P; Gronda M; Hedley DW
Mol Cancer Ther; 2004 Oct; 3(10):1239-48. PubMed ID: 15486191
[TBL] [Abstract][Full Text] [Related]
34. Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells.
Wang N; Wang Q; Tang H; Zhang F; Zheng Y; Wang S; Zhang J; Wang Z; Xie X
J Exp Clin Cancer Res; 2017 Dec; 36(1):172. PubMed ID: 29197410
[TBL] [Abstract][Full Text] [Related]
35. Sulforaphane inhibits gastric cancer stem cells via suppressing sonic hedgehog pathway.
Ge M; Zhang L; Cao L; Xie C; Li X; Li Y; Meng Y; Chen Y; Wang X; Chen J; Zhang Q; Shao J; Zhong C
Int J Food Sci Nutr; 2019 Aug; 70(5):570-578. PubMed ID: 30624124
[TBL] [Abstract][Full Text] [Related]
36. Caudatin Isolated from
Zhen X; Choi HS; Kim JH; Kim SL; Liu R; Ko YC; Yun BS; Lee DS
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32570844
[TBL] [Abstract][Full Text] [Related]
37. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.
Charafe-Jauffret E; Ginestier C; Iovino F; Tarpin C; Diebel M; Esterni B; Houvenaeghel G; Extra JM; Bertucci F; Jacquemier J; Xerri L; Dontu G; Stassi G; Xiao Y; Barsky SH; Birnbaum D; Viens P; Wicha MS
Clin Cancer Res; 2010 Jan; 16(1):45-55. PubMed ID: 20028757
[TBL] [Abstract][Full Text] [Related]
38. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
[TBL] [Abstract][Full Text] [Related]
39. miR-19 targeting of GSK3β mediates sulforaphane suppression of lung cancer stem cells.
Zhu J; Wang S; Chen Y; Li X; Jiang Y; Yang X; Li Y; Wang X; Meng Y; Zhu M; Ma X; Huang C; Wu R; Xie C; Geng S; Wu J; Zhong C; Han H
J Nutr Biochem; 2017 Jun; 44():80-91. PubMed ID: 28431267
[TBL] [Abstract][Full Text] [Related]
40. Dietary polyphenol quercetin targets pancreatic cancer stem cells.
Zhou W; Kallifatidis G; Baumann B; Rausch V; Mattern J; Gladkich J; Giese N; Moldenhauer G; Wirth T; Büchler MW; Salnikov AV; Herr I
Int J Oncol; 2010 Sep; 37(3):551-61. PubMed ID: 20664924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
